title: US Cancer Care System Ill-Equipped to Deliver New Advances to Patients.
authors.forename: Mary
authors.initials: M
authors.lastname: Rappaport
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D019033:Delivery of Health Care, Integrated / Q000191:economics / Q000458:organization & administration*; D004059:Diffusion of Innovation; D016527:Drug Costs; D006297:Health Services Accessibility / Q000191:economics / Q000458:organization & administration*; D006301:Health Services Needs and Demand / Q000191:economics / Q000458:organization & administration*; D006801:Humans; D008495:Medical Oncology / Q000191:economics / Q000458:organization & administration*; D020380:Needs Assessment; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D016896:Treatment Outcome; D014481:United States
chemical_list: D000970:Antineoplastic Agents